Internal Medicine, Pulmonary Disease · Madison, WI
NPI
1457334617
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
700 S Park St
Madison, WI, 53715
Phone (608) 260-2900
Groups this clinician bills Medicare through
Medicare paid, 2024
$107K
5,513 services
Medicare patients, 2024
411
Average age 74
Drug cost, 2024
$899K
2,651 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Baher N Habeeb was code 99214 (office e&m - established), 152 times for 133 patients. In total Baher N Habeeb billed 5,513 services in 66 codes, and Medicare paid $107K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 152 | 133 | $82.63 | $13K |
| 99291 Critical Care E&M | Facility | 77 | 41 | $155.62 | $12K |
| 99232 Hospital E&M - Subsequent | Facility | 64 | 27 | $58.15 | $3,722 |
| 94729 Pulmonary Function Testing | Office | 60 | 60 | $24.65 | $1,479 |
| 94726 Pulmonary Function Testing | Office | 58 | 58 | $25.55 | $1,482 |
| 99213 Office E&M - Established | Office | 57 | 55 | $56.25 | $3,206 |
| 99215 Office E&M - Established | Office | 54 | 44 | $115.85 | $6,256 |
| 94010 Pulmonary Function Testing | Office | 50 | 50 | $13.32 | $666 |
| 99233 Hospital E&M - Subsequent | Facility | 37 | 26 | $86.81 | $3,212 |
| J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | Office | 33 | 11 | $0.03 | $1.07 |
| 99204 Office E&M - New | Office | 30 | 30 | $106.49 | $3,195 |
| 94060 Pulmonary Function Testing | Office | 27 | 27 | $19.26 | $520 |
| 99205 Office E&M - New | Office | 20 | 20 | $159.40 | $3,188 |
| 36415 Venipuncture Blood Collection | Office | 20 | 16 | $8.65 | $173 |
| 99223 Hospital E&M - Initial | Facility | 17 | 17 | $127.93 | $2,175 |
By year: 2022 $117K for 4,543 services; 2023 $115K for 3,603 services; 2024 $107K for 5,513 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 20 | 16 | $8.65 | $173 |
Medicare prescription drug claims, 2024
In 2024, the drug Baher N Habeeb prescribed most often to Medicare patients was Incruse Ellipta (Umeclidinium Bromide), with 286 prescriptions and refills. In total Baher N Habeeb wrote 2,651 Medicare prescriptions that cost $899K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Incruse Ellipta Umeclidinium Bromide | 286 | 399 | 56 | $133K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 254 | 303 | 88 | $8,133 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 211 | 238 | 42 | $146K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 204 | 287 | 54 | $26K |
| Breo Ellipta Fluticasone/Vilanterol | 166 | 230 | 35 | $89K |
| Montelukast Sodium Generic | 147 | 379 | 43 | $2,051 |
| Spiriva Respimat Tiotropium Bromide | 130 | 172 | 35 | $88K |
| Arnuity Ellipta Fluticasone Furoate | 93 | 126 | 22 | $28K |
| Ventolin Hfa Albuterol Sulfate | 86 | 108 | 41 | $7,791 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 84 | 118 | 20 | $53K |
| Advair Hfa Fluticasone Propion/Salmeterol | 84 | 121 | 19 | $40K |
| Azithromycin Generic | 79 | 127 | 19 | $844 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 71 | 124 | 22 | $8,804 |
| Prednisone Generic | 68 | 109 | 41 | $372 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 61 | 94 | 13 | $43K |
Brand drugs: 1,754 claims; generic drugs: 897 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Baher N Habeeb were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.